Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 34 min ago
Peer-reviewedCC BY 4.0Systematic Reviews

Identification and mapping of patient-reported outcomes and overall quality of life outcomes in pregnant women with pre-existing diabetes: a scoping review

Abstract

Objective: Pre-existing diabetes during pregnancy increases the risk of adverse outcomes, including high levels of diabetes-related distress, anxiety, and depression. However, patient-reported outcomes (PROs) are underrepresented in research among pregnant women with pre-existing diabetes. To support the use and standardization of PROs, this study provides an overview of PROs assessed in prior studies involving pregnant women with pre-existing diabetes.

Research design and methods: Systematic searches were performed in Embase, Medline, PsycInfo, and Cochcrane Central, and identified studies were screened for eligibility. Subscales of patient-reported outcome measurements (PROMs) used in included studies were mapped into PRO-(sub)domains.

Results: In total, 57 reports from 49 studies were eligible for inclusion. Across the included studies, 61 unique PROMs were identified. Most PROMs ( n = 46) were only included in one study and were not pregnancy- nor diabetes-specific. Only one of the identified PROMs was developed specifically for pregnant women with pre-existing diabetes. The majority of the PROMs assessed symptom status, with mental symptoms being most commonly assessed. Across studies, depressive symptoms were most commonly assessed, followed by symptoms of fear, anxiety, worry, and distress.

Conclusion: Various PROMs are used in research involving pregnant women with pre-existing diabetes, reflecting heterogeneity in PROs assessed. A lack of scales specifically developed for these women is concerning, as pregnant women face unique challenges. These findings highlight the need to support and standardize PROs in studies among women with pre-existing diabetes.

Related

  1. Patient-reported outcomes between patients with young-onset type 2 and type 1 diabetes mellitus: results from the Taiwan diabetes registry
    Hsuan-Wei Lin, Fu-Shun Ko, Yen-Po Yeh +7
    BMC Endocrine DisordersPeer-reviewedCC BY-NC-ND 4.0Full textEndocrinology & metabolismDOAJPMC
  2. Comparing the validity of self-reported adherence measures for multiple micronutrient supplementation among pregnant women in Ethiopia: analysis of baseline data from a quasi-experimental study
    Habtamu Tamene, Yihunie Lakew, Nandita Kapadia-Kundu +6
    BMJ OpenPeer-reviewedLicence not statedGeneral medicineCrossref
  3. Immune Checkpoint Inhibitor‐Induced Diabetic Ketoacidosis in a Patient With Pre‐Existing Type 2 Diabetes: A Case Report
    Lingfen Zeng, Jieming Sun
    Clinical Case ReportsPeer-reviewedCC BY 4.0Full textOncologyPMC
  4. Performance and Safety of a Continuous Glucose Monitoring System in Pregnant Women With Gestational Diabetes Mellitus: A Multicenter, Open-Label Trial
    Jie Shen, Huiling Shang, Weiwei Zhu +1
    Journal of Diabetes Science and TechnologyPeer-reviewedLicence not statedFull textObstetrics, gynaecology & paediatricsPMC
  5. The correlation between risk perception and glycemic management decision-making behavior in pregnant women with gestational diabetes: a cross-sectional study
    Zining Wan, Yilin Huang, Huiying Ke +4
    BMC Public HealthPeer-reviewedCC BY-NC-ND 4.0Endocrinology & metabolismCrossref
BibTeX
@article{hansen2026identification,
  title = {{Identification and mapping of patient-reported outcomes and overall quality of life outcomes in pregnant women with pre-existing diabetes: a scoping review}},
  author = {Clara Holmskov Hansen and Manon Coolen and Jori Aalders and Christine Newman and Mette Juel Rothmann and Christina Anne Vinter and Dorte Møller Jensen},
  journal = {Systematic Reviews},
  year = {2026},
  month = nov,
  doi = {10.1186/s13643-026-03376-7},
  url = {https://link.springer.com/article/10.1186/s13643-026-03376-7},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Identification and mapping of patient-reported outcomes and overall quality of life outcomes in pregnant women with pre-existing diabetes: a scoping review
AU  - Clara Holmskov Hansen
AU  - Manon Coolen
AU  - Jori Aalders
AU  - Christine Newman
AU  - Mette Juel Rothmann
AU  - Christina Anne Vinter
AU  - Dorte Møller Jensen
PY  - 2026
DA  - 2026/11/16
JO  - Systematic Reviews
DO  - 10.1186/s13643-026-03376-7
UR  - https://link.springer.com/article/10.1186/s13643-026-03376-7
AB  - Objective: Pre-existing diabetes during pregnancy increases the risk of adverse outcomes, including high levels of diabetes-related distress, anxiety, and depression. However, patient-reported outcomes (PROs) are underrepresented in research among pregnant women with pre-existing diabetes. To support the use and standardization of PROs, this study provides an overview of PROs assessed in prior studies involving pregnant women with pre-existing diabetes.  Research design and methods: Systematic searches were performed in Embase, Medline, PsycInfo, and Cochcrane Central, and identified studies were screened for eligibility. Subscales of patient-reported outcome measurements (PROMs) used in included studies were mapped into PRO-(sub)domains.  Results: In total, 57 reports from 49 studies were eligible for inclusion. Across the included studies, 61 unique PROMs were identified. Most PROMs ( n = 46) were only included in one study and were not pregnancy- nor diabetes-specific. Only one of the identified PROMs was developed specifically for pregnant women with pre-existing diabetes. The majority of the PROMs assessed symptom status, with mental symptoms being most commonly assessed. Across studies, depressive symptoms were most commonly assessed, followed by symptoms of fear, anxiety, worry, and distress.  Conclusion: Various PROMs are used in research involving pregnant women with pre-existing diabetes, reflecting heterogeneity in PROs assessed. A lack of scales specifically developed for these women is concerning, as pregnant women face unique challenges. These findings highlight the need to support and standardize PROs in studies among women with pre-existing diabetes.
SN  - 2046-4053
ER  -